Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT06055348
What this trial is testing

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Who this might be right for
Serous Ovarian CancerAdvanced Ovarian Cancer
Biocity Biopharmaceutics Co., Ltd. 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT03480776
What this trial is testing

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Who this might be right for
Ovarian Cancer Prevention
Canadian Cancer Trials Group 117
Testing effectiveness (Phase 2)Study completedNCT00403429
What this trial is testing

MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 36
Post-approval studies (Phase 4)Study completedNCT01081626
What this trial is testing

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Who this might be right for
Ovulation Induction
Merck KGaA, Darmstadt, Germany 310
Testing effectiveness (Phase 2)UnknownNCT03467178
What this trial is testing

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.

Who this might be right for
Recurrent, Platinum-resistant Ovarian Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 119
Testing effectiveness (Phase 2)Study completedNCT01716715
What this trial is testing

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 111
Testing effectiveness (Phase 2)Study completedNCT00002558
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 108
Testing effectiveness (Phase 2)Ended earlyNCT00550654
What this trial is testing

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+3 more
National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03562897
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Who this might be right for
CarcinomaOvarian NeoplasmEndocrine Gland Neoplasm+10 more
Catalysis SL 40
Early research (Phase 1)UnknownNCT00527631
What this trial is testing

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Heidelberg University 8
Testing effectiveness (Phase 2)Study completedNCT00432094
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorOvarian CancerTeratoma
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)UnknownNCT04361370
What this trial is testing

Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer

Who this might be right for
Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer
Yonsei University 44
Testing effectiveness (Phase 2)Study completedNCT00477386
What this trial is testing

Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Indiana University 28
Testing effectiveness (Phase 2)Study completedNCT01078662
What this trial is testing

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Who this might be right for
OvarianBreastProstate+2 more
AstraZeneca 298
Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT00976183
What this trial is testing

Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

Who this might be right for
Ovarian Neoplasms
Gynecologic Oncology Associates 18
Not applicableLooking for participantsNCT04794322
What this trial is testing

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial CarcinomaFallopian Tube Neoplasms+12 more
Massachusetts General Hospital 250
Next Page